MX2024009025A - Preparacion liquida acuosa. - Google Patents
Preparacion liquida acuosa.Info
- Publication number
- MX2024009025A MX2024009025A MX2024009025A MX2024009025A MX2024009025A MX 2024009025 A MX2024009025 A MX 2024009025A MX 2024009025 A MX2024009025 A MX 2024009025A MX 2024009025 A MX2024009025 A MX 2024009025A MX 2024009025 A MX2024009025 A MX 2024009025A
- Authority
- MX
- Mexico
- Prior art keywords
- aqueous liquid
- liquid formulation
- cellulose
- arbekacin
- polyvinylpyrrolidone
- Prior art date
Links
- 239000012669 liquid formulation Substances 0.000 title abstract 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 abstract 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 abstract 1
- MKKYBZZTJQGVCD-XTCKQBCOSA-N arbekacin Chemical compound O([C@@H]1[C@@H](N)C[C@H]([C@@H]([C@H]1O)O[C@@H]1[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O1)O)NC(=O)[C@@H](O)CCN)[C@H]1O[C@H](CN)CC[C@H]1N MKKYBZZTJQGVCD-XTCKQBCOSA-N 0.000 abstract 1
- 229960005397 arbekacin Drugs 0.000 abstract 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 abstract 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 abstract 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 abstract 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 abstract 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 abstract 1
- 229920000609 methyl cellulose Polymers 0.000 abstract 1
- 239000001923 methylcellulose Substances 0.000 abstract 1
- 235000010981 methylcellulose Nutrition 0.000 abstract 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 abstract 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 abstract 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229920003169 water-soluble polymer Polymers 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Ophthalmology & Optometry (AREA)
- Inorganic Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022007774 | 2022-01-21 | ||
| PCT/JP2023/001725 WO2023140357A1 (ja) | 2022-01-21 | 2023-01-20 | 水性液剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2024009025A true MX2024009025A (es) | 2024-08-06 |
Family
ID=87348335
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2024009025A MX2024009025A (es) | 2022-01-21 | 2023-01-20 | Preparacion liquida acuosa. |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US12296015B2 (https=) |
| EP (1) | EP4467144A4 (https=) |
| JP (2) | JP7479744B2 (https=) |
| KR (1) | KR20240134913A (https=) |
| CN (1) | CN118613267A (https=) |
| CA (1) | CA3244189A1 (https=) |
| MX (1) | MX2024009025A (https=) |
| WO (1) | WO2023140357A1 (https=) |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5651499A (en) | 1979-10-01 | 1981-05-09 | Meiji Seika Kaisha Ltd | Aminoglycoside derivative and its preparation |
| JPS58134099A (ja) | 1982-02-05 | 1983-08-10 | Meiji Seika Kaisha Ltd | アミノ配糖体抗生物質の精製法 |
| JP2002097129A (ja) * | 2000-07-21 | 2002-04-02 | Rohto Pharmaceut Co Ltd | 点眼剤 |
| EP1683526B1 (en) * | 2003-11-14 | 2012-04-11 | Senju Pharmaceutical Co., Ltd. | Aqueous solution preparation containing aminoglycoside antibiotic and bromfenac |
| JP4736540B2 (ja) * | 2004-05-27 | 2011-07-27 | 参天製薬株式会社 | 眼科用粘稠化剤 |
| ES2510667T3 (es) | 2004-05-27 | 2014-10-21 | Santen Pharmaceutical Co., Ltd | Colirio |
| US8748402B2 (en) * | 2004-06-07 | 2014-06-10 | Bausch & Lomb Pharma Holdings Corp. | Ophthalmic formulations and uses thereof |
| CN105944105A (zh) | 2008-06-12 | 2016-09-21 | 前瞻生物治疗公司 | 一种眼科组合物中的防腐剂替代物聚维酮碘 |
| WO2010141831A1 (en) * | 2009-06-05 | 2010-12-09 | Aciex Therapeutics, Inc. | Ophthalmic formulations, methods of manufacture, and methods of using same |
| US8211450B2 (en) * | 2010-05-05 | 2012-07-03 | Senju Usa, Inc. | Ophthalmic composition |
| ES2532667T3 (es) | 2011-09-12 | 2015-03-30 | Meiji Seika Pharma Co., Ltd. | Composiciones acuosas que contienen arbekacina |
| JP2018522070A (ja) | 2015-07-27 | 2018-08-09 | キャタコア・インコーポレイテッドＣａｔａｃｏｒｅ， Ｉｎｃ． | 白内障の処置用組成物 |
| CN106474149A (zh) * | 2016-12-23 | 2017-03-08 | 常州润诺生物科技有限公司 | 一种复方氨基糖苷类抗生素的口服制剂及其制备方法与应用 |
| CN106420811A (zh) * | 2016-12-23 | 2017-02-22 | 常州润诺生物科技有限公司 | 一种氨基糖苷类抗生素的口服制剂及其制备方法与应用 |
-
2023
- 2023-01-20 WO PCT/JP2023/001725 patent/WO2023140357A1/ja not_active Ceased
- 2023-01-20 CN CN202380018185.6A patent/CN118613267A/zh active Pending
- 2023-01-20 JP JP2023554283A patent/JP7479744B2/ja active Active
- 2023-01-20 KR KR1020247024814A patent/KR20240134913A/ko active Pending
- 2023-01-20 CA CA3244189A patent/CA3244189A1/en active Pending
- 2023-01-20 EP EP23743349.5A patent/EP4467144A4/en active Pending
- 2023-01-20 MX MX2024009025A patent/MX2024009025A/es unknown
-
2024
- 2024-04-16 JP JP2024065941A patent/JP2024096898A/ja active Pending
- 2024-05-09 US US18/659,629 patent/US12296015B2/en active Active
-
2025
- 2025-04-08 US US19/173,248 patent/US20250235541A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA3244189A1 (en) | 2025-06-13 |
| US12296015B2 (en) | 2025-05-13 |
| JPWO2023140357A1 (https=) | 2023-07-27 |
| JP2024096898A (ja) | 2024-07-17 |
| EP4467144A1 (en) | 2024-11-27 |
| WO2023140357A1 (ja) | 2023-07-27 |
| US20250235541A1 (en) | 2025-07-24 |
| EP4467144A4 (en) | 2026-01-21 |
| KR20240134913A (ko) | 2024-09-10 |
| JP7479744B2 (ja) | 2024-05-09 |
| CN118613267A (zh) | 2024-09-06 |
| US20240307544A1 (en) | 2024-09-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2024008987A (es) | Derivado de heteroaril-pireno sustituido por anillo puenteado, y uso del mismo. | |
| SA521422143B1 (ar) | 15-pgdh مثبط | |
| MY189774A (en) | Atropine-containing aqueous composition | |
| EP4474017A3 (en) | New heterocyclic compounds | |
| JOP20220056A1 (ar) | مركبات rip1 تثبيطية وطرق عملها واستخدامها | |
| MX2024009539A (es) | Esteroides neuroactivos y composiciones de estos. | |
| BRPI0518553A2 (pt) | composiÇço farmacÊutica estÁvel, mÉtodo para estabilizaÇço de pelo menos um ingrediente farmaceuticamente ativo e mÉtodo de uso de celulose microcristalina silicificada | |
| MA53927B1 (fr) | Composition pharmaceutique pour une administration par voie orale comprenant un dérivé d'aminopyrimidine ou son sel | |
| MX2022008487A (es) | Degradadores de smarca2-vhl. | |
| CL2020002838A1 (es) | Suspensión acuosa concentrada en cápsulas que contiene un protector de herbicidas y un agente plaguicida | |
| WO2018234871A3 (en) | COMPOSITIONS FOR DRUG DELIVERY AND METHODS OF USE | |
| WO2022032073A3 (en) | Trpml modulators | |
| PH12021551412A1 (en) | Ursodeoxycholic acid-containing agent for treating or preventing presbyopia | |
| MX2020007521A (es) | Inhibidores de pi4kiii. | |
| WO2022099187A3 (en) | Sars-cov-2 antigen-binding proteins and uses thereof | |
| CA3156484A1 (en) | PHARMACEUTICAL MEDICINAL PRODUCT CONTAINING A HETEROCYCLIDENE ACETAMIDE DERIVATIVE | |
| MX2024009025A (es) | Preparacion liquida acuosa. | |
| EP4674401A3 (en) | Container accommodating an aqueous ophthalmic composition comprising delgocitinib | |
| NZ779146A (en) | Cyclic molecules as bruton’s tyrosine kinase inhibitor | |
| CL2024001073A1 (es) | Inhibidores de la replicación del virus de inmunodeficiencia humana | |
| NO20050839L (no) | Kontorprodukter inneholdende antimikrobielle midler | |
| RU2008102238A (ru) | Таблетка, содержащая труднорастворимый активный ингредиент | |
| MX2023007621A (es) | Metodo para expandir una comunidad compleja de microorganismos. | |
| WO2021224902A3 (en) | An improved process for the preparation of an aqueous ophthalmic solution of difluprednate | |
| MX2023002352A (es) | Formulaciones de un inhibidor de mcl-1. |